| CAS ID: | 1403-66-3 |
| Molecular Formula: | C21H43N5O7 |
| Molecular Weight: | 477.6 g/mol |
| Monoisotopic Mass: | 477.3162 g/mol |
| Class: | Small Molecule |
| Natural Product: | No |
| Other Names: | |
| Analysis: | Drug repositioning mechanism analysis |
Trial Record 1
| ClinicalTrial ID | NCT00376428 | Disease | Cystic fibrosis |
| Phase | Phase 2 | Status | Terminated |
| First Received | September 14, 2006 | Last Verified | February 25, 2015 |
| Sponsor | Assistance Publique - Hôpitaux de Paris | ||
Trial Record 2
| ClinicalTrial ID | NCT00749866 | Disease | Cystic fibrosis |
| Phase | Phase 4 | Status | Completed |
| First Received | September 9, 2008 | Last Verified | August 10, 2010 |
| Sponsor | University of Edinburgh | ||
| PubChem: | 3467 |
| ChEMBL: | CHEMBL329592 |